ENvue Medical (FEED) Shares Outstanding (Weighted Average) (2014 - 2026)
ENvue Medical (FEED) reported Shares Outstanding (Weighted Average) of $3.3 million for Q1 2026, up 5152.81% year-over-year from $62615.0 in Q1 2025, and up 423.29% quarter-over-quarter from $628534.0 in Q4 2025.
ENvue Medical (FEED) Shares Outstanding (Weighted Average) (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 13 years of Shares Outstanding (Weighted Average) data on file, last reported at $3.3 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $3.3 million, up 5152.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (up 5152.81% YoY), and the FY2025 annual result was $628534.0, up 2229.2% from the prior year.
- Shares Outstanding (Weighted Average) advanced to $3.3 million in Q1 2026 per FEED's latest filing, from $628534.0 in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $3.3 million in Q1 2026 and troughed at $25312.0 in Q2 2024.
- A 5-year average of $983303.3 and a median of $858434.0 in 2025 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Weighted Average) slumped 98.48% in 2024, then soared 5152.81% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.4 million in 2022, then sank by 88.79% to $159105.0 in 2023, then tumbled by 83.04% to $26985.0 in 2024, then surged by 2229.2% to $628534.0 in 2025, then jumped by 423.29% to $3.3 million in 2026.
- Business Quant data shows FEED's Shares Outstanding (Weighted Average) at $3.3 million in Q1 2026, $628534.0 in Q4 2025, and $858434.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 579.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 456.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 385.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 98.20 Mn |
| 10 | ENvue Medical | 2.71 Mn | 440,242.77 | -55,000.00 | 3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.29 Mn |
| Dec 31, 2025 | 628,534.00 |
| Sep 30, 2025 | 858,434.00 |
| Jun 30, 2025 | 526,534.00 |
| Mar 31, 2025 | 62,615.00 |
| Dec 31, 2024 | 26,985.00 |
| Sep 30, 2024 | 280,318.00 |
| Jun 30, 2024 | 25,312.00 |
| Mar 31, 2024 | 246,980.00 |
| Dec 31, 2023 | 159,105.00 |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 26.10 Mn |
| Jun 30, 2021 | 24.48 Mn |